beta-carotene has been researched along with Diabetic-Angiopathies* in 2 studies
1 trial(s) available for beta-carotene and Diabetic-Angiopathies
Article | Year |
---|---|
Effect of alpha-tocopherol and beta-carotene supplementation on macrovascular complications and total mortality from diabetes: results of the ATBC Study.
To determine whether alpha-tocopherol or beta-carotene supplementation affects diabetic macrovascular complications and total mortality.. This study was carried out as part of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, a double-blind, randomized trial with a 2x2 factorial design. A total of 29,133 middle-aged male smokers received either vitamin E 50 mg/day or beta-carotene 20 mg/day, or both, or placebo for a median of 6.1 years. At base-line, 1700 men had type 2 diabetes. Of these men, 662 were diagnosed with first-ever macrovascular complication, and 1142 died during the 19-year follow-up.. Neither supplementation affected the risk of macrovascular complication or total mortality during the intervention period. For the alpha-tocopherol-supplemented versus no alpha-tocopherol-supplemented, and beta-carotene-supplemented versus no beta-carotene-supplemented we found relative risk (RR) 0.84 (95% confidence interval (CI) 0.65-1.10) and RR 1.15 (95% CI 0.89-1.50) for macrovascular complication, respectively, and RR 1.00 (95% CI 0.80-1.25) and RR 1.06 (95% CI 0.85-1.33) for total mortality, respectively. No essential changes were found in these effects when the follow-up was extended up to 19 years.. Alpha-tocopherol or beta-carotene supplementation has no protective effect on macrovascular outcomes or total mortality of diabetic male smokers. Topics: Aged; alpha-Tocopherol; beta Carotene; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Double-Blind Method; Finland; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Smoking; Stroke; Survival Rate; Treatment Outcome; Vitamins | 2010 |
1 other study(ies) available for beta-carotene and Diabetic-Angiopathies
Article | Year |
---|---|
Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease.
To evaluate the association between type 2 diabetes and newly reported Parkinson's disease.. Our study included 21,841 participants in the Physicians' Health Study, a cohort of U.S. male physicians. Diabetes and Parkinson's disease were self-reported via questionnaire. We used time-varying Cox regression to calculate adjusted relative risk (RR) for Parkinson's disease.. Over 23 years, 556 individuals with Parkinson's disease were identified. Subjects with diabetes had an increased Parkinson's disease risk (multivariable-adjusted RR 1.34 [95% CI 1.01-1.77]). The association remained significant after exclusion of those with known vascular disease. The diagnosis of diabetes was clustered around the diagnosis of Parkinson's disease and was more apparent among men with short diabetes duration and those without complications from diabetes.. Results of this large prospective study in men do not suggest that diabetes is a preceding risk factor for Parkinson's disease. Whether the positive association may be explained by ascertainment bias or a common underlying biological mechanism remains to be established. Topics: Adult; Aged; Aspirin; beta Carotene; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Parkinson Disease; Patient Selection; Physicians; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors | 2008 |